Skip to search boxSkip to navigationSkip to main content

Cannabinoids, sleep, and the MCH system

  • ,
  • Daniela Morales-Lara
    ,
  • José Carlos Pastrana-Trejo
    ,
  • Lorena Macías-Triana
    ,
  • Karen Romero-Cordero
    ,
  • Miriel de-la-Cruz
  • ,
  • Intercontinental Neuroscience Research Group
    ,
  • Universidad Anáhuac
    ,
  • Centro de Investigacion Cientifica de Yucatan
Research Output: Chapter in Book/Report/Conference proceeding Chapter Peer-review

Publication Information

Output type

Research Output: Chapter in Book/Report/Conference proceeding Chapter Peer-review

Host publication Subtitle

Molecular, Functional and Clinical Aspects

Original language

English

Pages from-to (Number of pages)

Pages 121-130 (10 pages)

Publication milestones

  • Published - 17/04/2018

Publication status

Published - 17/04/2018

Publisher

Taylor and Francis
9783319757643

ISBN (Electronic)

9783319757650

Publication IDs

  • Scopus: 85070025856

Host publication title

Melanin-Concentrating Hormone and Sleep

Abstract

Marijuana is a colloquial name given to Cannabis sativa, which has been used for diverse purposes, including as a therapeutical element for multiple health issues. The neurobiological effects of C. sativa involve a complex biological machinery including receptors, named CB1 and CB2 cannabinoid receptors. These receptors recognize endogenous cannabinoid-like compounds, such as anandamide and 2-arachinonolglycerol which seems to display sleep-inducing properties. Along decades, the study of the putative role of exogenous and endogenous cannabinoids in sleep modulation has brought critical data. Since endocannabinoids have been described in sleep-related brain areas, intriguing issues regarding whether hypothalamic substrates, such as MHC, may be interacting with the endocannabinoids have been raised.